SECOND OPINION: DEBUNKING BIG PHARMA’S BOGUS INNOVATION RHETORIC
Brand Name Drug Companies Claim Lowering Rx Prices Will Undercut R&D — The Facts Disagree
For far too long Big Pharma has used the excuse that research and development (R&D) costs justify out-of-control prescription drug prices and that solutions to lower prices threaten innovation into new breakthroughs. These tired arguments, which Big Pharma wields like a shield to protect the industry’s anti-competitive and price-hiking practices, simply don’t hold up to scrutiny.